STINISSEN, Piet

Email Alert RSS Feed

Profile

Full Name
STINISSEN, Piet
Email
piet.stinissen@uhasselt.be
 
Loading... 5 0 5 0 false
Loading... 6 0 5 0 false

Publications

Results 81-100 of 105 (Search time: 0.009 seconds).

show all
Issue DateTitleContributor(s)TypeCat.
812008Quantitative analysis of differentially expressed brain proteins in the EAE-model for multiple sclerosisDANIELS, Ruth; VAN SUMMEREN, Anke; BAETEN, Kurt; NOBEN, Jean-Paul; HENDRIKS, Jerome; STINISSEN, Piet; ROBBEN, JohanJournal ContributionM
822008Leukaemia inhibitory factor induces an anti-apoptotic response in oligodendrocytes through Akt-phosphorylation and upregulation of 14-3-3SLAETS, Leen; DUMONT, Debora; VANDERLOCHT, Joris; NOBEN, Jean-Paul; Leprince, P.; ROBBEN, Johan; HENDRIKS, Jerome; STINISSEN, Piet; HELLINGS, NielsJournal ContributionM
832008Monoclonal antibody production by immortalization of B cells from the thymus of myasthenia gravis patients.Vrolix, K; FRAUSSEN, Judith; Meulemans, E; DE BAETS, Marc; STINISSEN, Piet; SOMERS, Veerle; Martinez-Martinez, PilarJournal ContributionM
842007Reduced number of blood circulating foxp3+CD25highCD4+regulatory T cells and a decreased foxp3 expression at the single-cell level in patients with relapsing-remitting multiple sclerosisVENKEN, Koen; HELLINGS, Niels; SOMERS, Veerle; Meuwissen, Pieter; THEWISSEN, Marielle; HENSEN, Karen; RUMMENS, Jean-Luc; STINISSEN, PietJournal ContributionM
852007The ambivalent nature of T-cell infiltration in the central nervous system of patients with multiple sclerosisVANDERLOCHT, Joris; HELLINGS, Niels; HENDRIKS, Jerome; STINISSEN, PietJournal ContributionA1
862007Leukemia inhibitory factor-mediated protection of oligodendrocytes: implications for multiple sclerosisSLAETS, Leen; DUMONT, Debora; VANDERLOCHT, Joris; Leprince, P.; ROBBEN, Johan; HENDRIKS, Jerome; STINISSEN, Piet; HELLINGS, NielsJournal ContributionM
872007Immune mediated protection in multiple sclerosis: A role for neurokines in oligodendrocyte survival and macrophage modulationHELLINGS, Niels; HENDRIKS, Jerome; CARMANS, Sofie; SLAETS, Leen; DUMONT, Debora; VANDERLOCHT, Joris; STINISSEN, PietJournal ContributionM
882007Exercise therapy in multiple sclerosis patients: effects of resistance training, additional electro-stimulation and whole body vibration on muscle functional capacityBROEKMANS, Tom; ALDERS, Geert; Roelandts, M.; Feys, F.; MEESEN, Raf; Charlier, C.; VAN HOOF, Elke; STINISSEN, Piet; OP 'T EIJNDE, BertJournal ContributionM
892007Functional magnetic resonance imaging for preoperative localisation of eloquent brain areas relative to brain tumours: Clinical implementation in a regional hospitalGEERTS, Joëlle; Martens, Mieke; VANDEVENNE, Jan; Gelin, G.; Grieten, m.; WEYNS, Frank; STINISSEN, Piet; PALMERS, Yvan; Wuyts, J.Journal ContributionA1
902006T cell vaccination in multiple sclerosis with CSF-derived activated cd4+T cells: results of a placebo-controlled trialSTINISSEN, Piet; MEDAER, Rob; HELLINGS, Niels; VANROOSE, Erwin; Barkhof, F.; RAUS, JefJournal ContributionM
912006T-cell vaccination in MS with CSF-derived activated CD4(+) T-cells: Results of a placebo-controlled trialSTINISSEN, Piet; MEDAER, Rob; HELLINGS, Niels; Barkhof, F.; RAUS, JefJournal ContributionM
922006Influence of leukaemia inhibitory factor on macrophage function in vitro and during experimental autoimmune encephalomyelitisHENDRIKS, Jerome; HELLINGS, Niels; VANDERLOCHT, Joris; STINISSEN, PietJournal ContributionM
932006Current trends in multiple sclerosis research: an update on pathogenic conceptsVANDERLOCHT, Joris; HELLINGS, Niels; HENDRIKS, Jerome; STINISSEN, PietJournal ContributionA1
942006Effects of IFN-beta, leptin and sinivastatin on LIF secretion by T lymphocytes of MS patients and healthy controlsVANDERLOCHT, Joris; HENDRIKS, Jerome; VENKEN, Koen; STINISSEN, Piet; HELLINGS, NielsJournal ContributionM
952006No association of leukemia inhibitory factor (LIF) DNA polymorphisms with multiple sclerosisVANDERLOCHT, Joris; BURZYKOWSKI, Tomasz; SOMERS, Veerle; STINISSEN, Piet; HELLINGS, NielsJournal ContributionA1
962004Leukemia inhibitory factor is produced by myelin reactive T-cells and protects against cytokine induced oligodendrocyte cell deathVANDERLOCHT, Joris; HELLINGS, Niels; VANDENABEELE, Frank; MOREELS, Marjan; Antel, J.; RAUS, Jef; STINISSEN, PietJournal ContributionM
972003Long-term effects of T cell vaccination in multiple sclerosisSTINISSEN, Piet; HERMANS, Guy; HELLINGS, Niels; MEDAER, Rob; RAUS, JefProceedings PaperC1
982002Dynamic T cell receptor clonotype changes in synovial tissue of patients with early rheumatoid arthritis: Effects of treatment with cyclosporin A (Neoral (R))VANDER BORGHT, Ann; De Keyser, F.; De Backer, M.; Malaise, M.; Baeten, D.; Van den Bosch, F.; Veys, E.M.; GEUSENS, Piet; RAUS, Jef; STINISSEN, PietJournal ContributionA1
992002Longitudinal study of antimyelin T-cell reactivity in relapsing-remitting multiple sclerosis association with clinical and MRI activityHELLINGS, Niels; Gellin, G.; MEDAER, Rob; BRUCKERS, Liesbeth; PALMERS, Yvan; RAUS, Jef; STINISSEN, PietJournal ContributionA1
1002002Interferon-gamma-induced calcium influx in T lymphocytes of multiple sclerosis and rheumatoid arthritis patients: a complementary mechanism for T cell activation?BUNTINX, Mieke; AMELOOT, Marcel; STEELS, Paul; JANSSEN, Paul; MEDAER, Rob; GEUSENS, Piet; RAUS, Jef; STINISSEN, PietJournal ContributionA1
show all